The Search for New 2-18F-FDG PET/CT Imaging Biomarkers in Advanced Ovarian Cancer Patients: Focus on Peritoneal Staging for Guiding Precision Medicine and Management Decisions

Clin Nucl Med. 2021 Nov 1;46(11):906-907. doi: 10.1097/RLU.0000000000003784.
No abstract available

Publication types

  • Comment

MeSH terms

  • Biomarkers
  • Female
  • Fluorodeoxyglucose F18*
  • Humans
  • Ovarian Neoplasms* / diagnostic imaging
  • Positron Emission Tomography Computed Tomography
  • Positron-Emission Tomography
  • Precision Medicine

Substances

  • Biomarkers
  • Fluorodeoxyglucose F18